IRIS UniCatt

Masucci, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.207
EU - Europa 3.526
AS - Asia 3.522
SA - Sud America 659
AF - Africa 112
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.067
SG - Singapore 1.616
DE - Germania 902
CN - Cina 779
IT - Italia 693
SE - Svezia 525
BR - Brasile 520
VN - Vietnam 335
FR - Francia 332
PL - Polonia 257
IE - Irlanda 151
GB - Regno Unito 145
IN - India 130
HK - Hong Kong 127
FI - Finlandia 119
UA - Ucraina 113
ID - Indonesia 97
JP - Giappone 86
CA - Canada 70
RU - Federazione Russa 62
BD - Bangladesh 52
AR - Argentina 51
TR - Turchia 47
AT - Austria 44
NL - Olanda 43
MX - Messico 42
KR - Corea 39
IQ - Iraq 33
ES - Italia 28
ZA - Sudafrica 28
BE - Belgio 26
EC - Ecuador 20
MA - Marocco 20
SA - Arabia Saudita 20
AU - Australia 18
CZ - Repubblica Ceca 18
PH - Filippine 17
VE - Venezuela 16
CH - Svizzera 15
LT - Lituania 14
PK - Pakistan 14
IR - Iran 13
CL - Cile 12
CO - Colombia 12
JO - Giordania 11
NP - Nepal 11
NG - Nigeria 10
TW - Taiwan 10
AZ - Azerbaigian 9
MY - Malesia 9
TN - Tunisia 9
BO - Bolivia 8
EG - Egitto 8
PE - Perù 8
TH - Thailandia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CY - Cipro 7
GR - Grecia 7
IL - Israele 7
CI - Costa d'Avorio 6
DZ - Algeria 6
KE - Kenya 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
HR - Croazia 5
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
PY - Paraguay 5
BB - Barbados 4
HN - Honduras 4
LB - Libano 4
PA - Panama 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
GH - Ghana 3
KG - Kirghizistan 3
MD - Moldavia 3
NO - Norvegia 3
SN - Senegal 3
AO - Angola 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
LV - Lettonia 2
MM - Myanmar 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
Totale 12.034
Salva come PNG Salva come JPEG
Città #
Singapore 897
Chandler 442
Ashburn 438
San Jose 428
Warsaw 240
Beijing 159
Dublin 149
Rome 136
Ann Arbor 116
Hong Kong 116
New York 113
Ho Chi Minh City 105
Los Angeles 103
Milan 88
Jakarta 85
Lauterbourg 85
Hanoi 84
Fairfield 83
Hefei 83
Jacksonville 81
Tokyo 80
Chicago 72
Woodbridge 70
Wilmington 69
The Dalles 65
Boston 61
Council Bluffs 61
Frankfurt am Main 61
San Mateo 61
Munich 58
Dearborn 54
Marseille 54
Houston 53
Nanjing 47
St Louis 47
São Paulo 47
Helsinki 44
Princeton 43
Cattolica 41
Moscow 40
Dallas 38
Seattle 37
Seoul 37
Redwood City 30
Turku 30
London 27
Stockholm 27
Nuremberg 26
Santa Clara 26
Izmir 25
Pune 25
Boardman 23
Kent 23
Buffalo 22
Nürnberg 22
Orem 22
Vienna 22
Hangzhou 21
Johannesburg 21
Lawrence 21
Paris 21
Atlanta 20
Brussels 20
Cambridge 20
Lappeenranta 20
Montreal 19
Zhengzhou 19
Da Nang 18
Denver 18
Redmond 18
Baghdad 17
Brooklyn 17
Falkenstein 17
North Bergen 17
Poplar 17
San Francisco 17
Düsseldorf 16
Nanchang 16
Tianjin 16
Augusta 15
Dhaka 15
Mexico City 14
Rio de Janeiro 14
Shanghai 14
Toronto 14
Washington 14
Falls Church 13
Kunming 13
Phoenix 13
Guangzhou 12
Hyderabad 12
Melbourne 12
Amman 11
Florence 11
Hebei 11
Manchester 11
Mountain View 11
Norwalk 11
Shenyang 11
Zurich 11
Totale 6.290
Salva come PNG Salva come JPEG
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 478
Consorzio di probiotici / Probiotic mixture 362
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 268
Whole-genome sequencing reveals host factors underlying critical COVID-19 217
The role of diet on gut microbiota composition 214
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 207
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 207
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 197
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 179
The effect of different antibiotic regimens on bacterial resistance: a systematic review 179
Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases 175
Polymerase chain reaction-reverse cross-blot hybridization assay in the diagnosis of sporotrichoid Mycobacterium marinum infection 171
Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice 166
An explainable model of host genetic interactions linked to COVID-19 severity 164
Entamoeba dispar: A Rare Case of Enteritis in a Patient Living in a Nonendemic Area 164
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm 163
Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection. 163
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 162
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 159
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 159
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 158
European consensus conference on faecal microbiota transplantation in clinical practice 156
Intestinal Parasitic Infections in Internationally Adopted Children: A 10-Year Retrospective Study 156
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 152
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. 149
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 148
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 147
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 147
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 144
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 143
Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates 143
A patient with acute myeloid leukemia and a solid mass in the colon. 142
Multiple malaria infection in a pregnant woman from Nigeria: detection by multiplex PCR 135
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 133
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 133
International consensus statement on microbiome testing in clinical practice 132
Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016 131
Reply to Seligman 130
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: a pre-post analysis in a Third Level Referral Center 129
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 127
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 127
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 126
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 126
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 126
Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study 125
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 124
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 119
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 118
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 113
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 111
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 110
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 110
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 110
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 109
Fecal microbiota transplantation: What’s new? 108
Mapping the human genetic architecture of COVID-19 108
How the gut parasitome affects human health 106
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 106
Characterizing peri-implant and sub-gingival microbiota through culturomics. First isolation of some species in the oral cavity. A pilot study 105
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 105
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 105
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 101
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 100
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 100
Genetic mechanisms of critical illness in COVID-19 99
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies 97
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 97
Laboratory handling practice for faecal microbiota transplantation 97
Conjonctival papilloma and human papillomavirus: identification of HPV types by PCR. 96
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 95
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 94
Laboratory handling practice for faecal microbiota transplantation 93
SARS-CoV-2 vaccines and donor recruitment for FMT 92
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 91
A literature review of metagenomics and culturomics of the peri-implant microbiome: Current evidence and future perspectives 91
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 90
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 86
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 86
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes 85
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 85
The Italian national faecal microbiota transplantation program: A coordinated effort against Clostridioides difficile infection 81
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 79
comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis 78
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone 77
PCR-reverse cross blot hybridization assay as an useful diagnostic tool in a case of Mycobacterium marinum sporotrichoid infection 74
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions 67
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 67
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 65
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 65
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel 65
Culturomic and quantitative real-time-polymerase chain reaction analyses for early contamination of abutments with different surfaces: A randomized clinical trial 64
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 62
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel 55
Clinical and molecular characterization of COVID-19 hospitalized patients 51
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 48
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 41
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 29
Totale 12.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 63 11
2021/2022611 69 27 18 29 35 27 10 68 34 34 155 105
2022/20231.475 195 176 90 155 104 165 89 127 194 95 53 32
2023/2024943 59 225 39 66 44 146 77 25 19 50 93 100
2024/20251.977 39 70 135 110 156 72 97 79 260 228 402 329
2025/20265.169 710 151 306 593 908 620 896 224 341 404 16 0
Totale 12.229